StockTipsArenaBeta

BUY Natco Pharma Ltd — IDBI Capital

BUYNatco Pharma Ltd
Natco Pharma share price target & all analyst calls

byIDBI CapitalHorizon: NA (inferred Swing (≤2wk))7 Jul 2026via IDBI Capital Research Calls Telegram

Entry₹965Stated
Target₹1,010
Total upside +4.66% (call closed)
Stop loss₹940-2.59% risk
At expiry₹949.8520 Jul 2026, 3:30 pm
Expired-1.57%
Follow IDBI Capital for new calls(25% target hit, 371 closed calls)Get alertsWatch NATCOPHARM for new buy/sell callsGet alertsSee 147 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 20 Jul 2026
5 supporting0 opposing
Supports the BUY call (5)

Natco Pharma Shares Gain After US FDA Tentative Approval for Generic Cancer Drug

NewsNdtv-Profit·20 Jul · today

(opens in new tab)

Natco Pharma shares surge 5% after US FDA's tentative nod Olaparib tablets

NewsEt-Markets·20 Jul · today

(opens in new tab)

Natco Pharma receives USFDA tentative approval for generic Lynparza tablets

NewsCnbc-Tv18·18 Jul · yesterday

(opens in new tab)

Natco Pharma Ltd has received tentative approval from the U.S. FDA for its Olaparib Tablets. This is a significant regulatory milestone.

BSE · Company Update·18 Jul · yesterday

(opens in new tab)

Natco Pharma Ltd has completed the acquisition of an additional 13.25% stake in Adcock Ingram Holdings Proprietary Limited.

NSE · Press Release·14 Jul · 6d ago

(opens in new tab)
Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Natco Pharma

All analyst calls on Natco Pharma

More from IDBI Capital

Every call and its outcome